Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Total article views   Abstract views HTML views PDF downloads Totals
3,230 Dovepress* 2,503 434+ 751 2,937
PubMed Central* 0 293 124 293
Totals 2,503 727 875 3,230
*Since 19 September 2018
+Since July 2016

View citations on PubMed Central and Google Scholar